PSEN2 Back

presenilin 2 (Alzheimer disease 4)

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of PSEN2
Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1 or PSEN2) or the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor such that, they either directly regulate gamma-secretase activity, or themselves act are protease enzymes. Two alternatively spliced transcript variants encoding different isoforms of PSEN2 have been identified.

Community Annotation of PSEN2 Add / Edit PSEN2: Annotations

No community annotations yet for PSEN2.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

PSEN2 is highly significantly mutated in
(none)
PSEN2 is significantly mutated in
(none)
PSEN2 is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for PSEN2